Innovative Saltwater Nebuliser to Treat Cystic Fibrosis, Parion Sciences Reveals

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Observing surfers with cystic fibrosis (CF) led scientists to discover that the inhaled mist of seawater has a therapeutic effect on the lung problems associated with the disease. Now the findings have been used by pharmaceutical company Parion Sciences and product development firm Cambridge Consultants in a revolutionary new aerosol delivery system. It enables CF sufferers to get the benefits of saltwater treatment in their own homes overnight while they sleep.

Hey, check out all the engineering jobs. Post your resume today!

MORE ON THIS TOPIC